1. American Psychiatric Association . Practice guideline for the treatment of patients with major depressive disorder. Washington, DC: American Psychiatric Association, 2010.
Google Scholar2. National Institute for Health and Care Excellence . Depression in adults: recognition and management, nice.org.uk/guidance/cg90 (2009, accessed 17 October 2017).
Google Scholar3. Borges, S, Chen, YF, Laughren, TP, et al. Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. J Clin Psychiatry 2014; 75: 205–214.
Google Scholar | Crossref | Medline | ISI4. Geddes, JR, Carney, SM, Davies, C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653–661.
Google Scholar | Crossref | Medline | ISI5. Baldessarini, RJ, Tondo, L. Effects of treatment discontinuation in clinical psychopharmacology. Psychother Psychosom 2019; 88: 65–70.
Google Scholar | Crossref | Medline6. El-Mallakh, RS, Briscoe, B. Studies of long-term use of antidepressants: how should the data from them be interpreted? CNS Drugs 2012; 26: 97–109.
Google Scholar | Crossref | Medline7. Hengartner, MP. How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding. Ther Adv Psychopharmacol 2020; 10: 2045125320921694.
Google Scholar | SAGE Journals | ISI8. Recalt, AM, Cohen, D. Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000-2017. Psychother Psychosom 2019; 88: 105–113.
Google Scholar | Crossref | Medline9. Van Leeuwen, E, van Driel, ML, Horowitz, MA, et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev 2021; 4: CD013495.
Google Scholar | Medline10. Baldwin, DS, Montgomery, SA, Nil, R, et al. Discontinuation symptoms in depression and anxiety disorders. Int J Neuropsychopharmacol 2007; 10: 73–84.
Google Scholar | Crossref | Medline | ISI11. Michelson, D, Fava, M, Amsterdam, J, et al. Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry 2000; 176: 363–368.
Google Scholar | Crossref | Medline | ISI12. Rosenbaum, JF, Fava, M, Hoog, SL, et al. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44: 77–87.
Google Scholar | Crossref | Medline | ISI13. Healy, D. Treatment-induced stress syndromes. Med Hypotheses 2010; 74: 764–768.
Google Scholar | Crossref | Medline14. Andrews, PW, Kornstein, SG, Halberstadt, LJ, et al. Blue again: perturbational effects of antidepressants suggest monoaminergic homeostasis in major depression. Front Psychol 2011; 2: 159.
Google Scholar | Crossref | Medline15. Fava, GA. May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Ther Adv Psychopharmacol 2020; 10: 2045125320970325.
Google Scholar | SAGE Journals | ISI16. Greenhouse, JB, Stangl, D, Kupfer, DJ, et al. Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry 1991; 48: 313–318.
Google Scholar | Crossref | Medline17. Kaymaz, N, van Os, J, Loonen, AJ, et al. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008; 69: 1423–1436.
Google Scholar | Crossref | Medline | ISI18. Viguera, AC, Baldessarini, RJ, Friedberg, J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998; 5: 293–306.
Google Scholar | Crossref | Medline | ISI19. Hengartner, MP, Davies, J, Read, J. Antidepressant withdrawal - the tide is finally turning. Epidemiol Psychiatr Sci 2019; 29: e52.
Google Scholar | Crossref | Medline20. Eaton, WW, Shao, H, Nestadt, G, et al. Population-based study of first onset and chronicity in major depressive disorder. Arch Gen Psychiatry 2008; 65: 513–520.
Google Scholar | Crossref | Medline21. Hardeveld, F, Spijker, J, De Graaf, R, et al. Recurrence of major depressive disorder across different treatment settings: results from the NESDA study. J Affect Disord 2013; 147: 225–231.
Google Scholar | Crossref | Medline | ISI22. Ten Have, M, de Graaf, R, van Dorsselaer, S, et al. Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort. Acta Psychiatr Scand 2018; 137: 503–515.
Google Scholar | Crossref | Medline23. Fava, GA, Gatti, A, Belaise, C, et al. Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychother Psychosom 2015; 84: 72–81.
Google Scholar | Crossref | Medline | ISI24. Fava, GA, Benasi, G, Lucente, M, et al. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom 2018; 87: 195–203.
Google Scholar | Crossref | Medline25. Jha, MK, Rush, AJ, Trivedi, MH. When discontinuing SSRI antidepressants is a challenge: management tips. Am J Psychiatry 2018; 175: 1176–1184.
Google Scholar | Crossref | Medline26. Goodwin, GM, Emsley, R, Rembry, S, et al.; Agomelatine Study Group. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2009; 70: 1128–1137.
Google Scholar | Crossref | Medline | ISI27. Rohatgi, A. WebPlotDigitizer, https://automeris.io/WebPlotDigitizer (accessed 20 December 2020).
Google Scholar28. R Core Team . R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2020.
Google Scholar29. Cohen, D, Recalt, A. Discontinuing psychotropic drugs from participants in randomized controlled trials: a systematic review. Psychother Psychosom 2019; 88: 96–104.
Google Scholar | Crossref | Medline30. Sim, K, Lau, WK, Sim, J, et al. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol 2015; 19: pyv076.
Google Scholar31. Chouinard, G, Chouinard, VA. New classification of selective serotonin reuptake inhibitor withdrawal. Psychother Psychosom 2015; 84: 63–71.
Google Scholar | Crossref | Medline32. Horowitz, MA, Taylor, D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry 2019; 6: 538–546.
Google Scholar | Crossref | Medline33. Ghaemi, SN. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression. Bipolar Disord 2008; 10: 957–968.
Google Scholar | Crossref | Medline | ISI34. Hengartner, MP. Methodological flaws, conflicts of interest, and scientific fallacies: implications for the evaluation of antidepressants’ efficacy and harm. Front Psychiatry 2017; 8: 275.
Google Scholar | Crossref | Medline35. Pigott, HE, Leventhal, AM, Alter, GS, et al. Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom 2010; 79: 267–279.
Google Scholar | Crossref | Medline | ISI36. de Vries, YA, Roest, AM, de Jonge, P, et al. The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression. Psychol Med 2018; 48: 2453–2455.
Google Scholar | Crossref | Medline37. Melander, H, Ahlqvist-Rastad, J, Meijer, G, et al. Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 2003; 326: 1171–1173.
Google Scholar | Crossref | Medline38. Turner, EH, Matthews, AM, Linardatos, E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008; 358: 252–260.
Google Scholar | Crossref | Medline | ISI39. Tint, A, Haddad, PM, Anderson, IM. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. J Psychopharmacol 2008; 22: 330–332.
Google Scholar | SAGE Journals | ISI40. Haddad, PM, Anderson, IM. Recognising and managing antidepressant discontinuation symptoms. Adv Psychiatr Treat 2007; 13: 447–457.
Google Scholar | Crossref41. Ghaemi, SN, Selker, HP. Maintenance efficacy designs in psychiatry: randomized discontinuation trials - enriched but not better. J Clin Transl Sci 2017; 1: 198–204.
Google Scholar | Crossref | Medline